CIK 0001590750
- Large accelerated filer
Viridian Therapeutics, Inc.\DE
Sign in to watch- Ticker
- VRDN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 471187261
- Phone
- +1 617-272-4600
- Business address
- 221 CRESCENT STREET, SUITE 103A, WALTHAM, MA, 02453
- Former names
- MIRAGEN THERAPEUTICS, INC., SIGNAL GENETICS, INC., SIGNAL GENETICS LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $348,194
- in 1 filing
Net −$348,194. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-11-13 | Logos Global Master Fund LP 10% owner | Purchase | +126,667 | $14.84 | $1.9M | 550,000 |
| 2020-11-09 | Logos Global Master Fund LP 10% owner | Purchase | +250,000 | $1.10 | $274K | 6,250,000 |
| 2020-11-09 | Logos Global Master Fund LP 10% owner | Purchase | +100,000 | $1.16 | $116K | 6,350,000 |
Page 1 of 1 · 3 trades